Consensus Recommendations for Treatment of the Upper Face With LetibotulinumtoxinA

Area of Science:

• Aesthetic Medicine
• Dermatology
• Cosmetic Procedures

Background:

• Facial lines, particularly on the upper face, are a common aesthetic concern.
• Botulinum toxin type A is a widely used treatment for dynamic facial wrinkles.
• Standardized guidelines are needed for optimal and safe application of newer formulations like letibotulinumtoxinA.

Purpose of the Study:

• To develop expert-driven clinical guidelines for the aesthetic treatment of upper facial lines using letibotulinumtoxinA.
• To provide recommendations on injection sites, dosage, and techniques for forehead horizontal lines, glabellar frown lines, and lateral canthal lines.
• To enhance the safety and efficacy of letibotulinumtoxinA treatments by considering relevant anatomy and patient factors.

Main Methods:

• Convened a panel of seven aesthetic experts from South Korea and Australia.
• Experts provided consensus-based recommendations for letibotulinumtoxinA treatment.
• Considered relevant facial anatomy, patient assessment, selection criteria, and complication minimization strategies.

Main Results:

• Developed specific recommendations for treating forehead horizontal lines, glabellar frown lines, and lateral canthal lines.
• Guidelines include details on optimal injection sites, appropriate dosage ranges, and precise injection techniques.
• Addressed patient selection and anatomical considerations to minimize potential adverse events.

Conclusions:

• The developed guidelines offer a standardized approach for practitioners treating upper facial lines with letibotulinumtoxinA.
• These recommendations aim to improve treatment outcomes, ensuring both safety and efficacy for aesthetic practitioners.
• The guidelines serve as a valuable resource for clinicians of all skill levels using letibotulinumtoxinA in aesthetic practice.